Comprehensive evaluation of fibrin glue as a local drug-delivery system - Efficacy and safety of sustained release of vancomycin by fibrin glue against local methicillin-resistant Staphylococcus aureus infection

Journal of Artificial Organs

Volumn 17, Issue 1, 2014, Pages 42-49

  Ozaki, Shinichi ^a   Saito, Aya ^a   Nakaminami, Hidemasa ^b   Ono, Minoru ^a   Noguchi, Norihisa ^b   Motomura, Noboru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Fibrin glue; Graft infection; Methicillin resistant Staphylococcus aureus (MRSA)

Indexed keywords

FIBRIN GLUE; SEALANT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD SAMPLING; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; GRAFT INFECTION; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; VISCOSITY; WOUND CLOSURE; ANIMAL; BLOOD; LEWIS RAT; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG DELIVERY SYSTEMS; FIBRIN TISSUE ADHESIVE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, INBRED LEW; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84897111067     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-013-0746-9     Document Type: Article

References (30)

1. Suzuki G, Saito S, Ishii T, Motojima S, Tokuhashi Y, Ryu J. Previous fracture surgery is a major risk factor of infection after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2011;19:2040-4.
2. Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg. 2008;47:264-9. (Pubitemid 351172668)
3. Truninger K, Attenhofer Jost CH, Seifert B, Vogt PR, Follath F, et al. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart. 1999;82:714-20.
4. Tom TS, Kruse MW, Reichman RT. Update: methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery. Ann Thorac Surg. 2009;88:695-702.
5. Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004;77:676-83. (Pubitemid 38186531)
6. Karra R, McDermott L, Connelly S, Smith P, Sexton DJ, Kaye KS. Risk factors for 1-year mortality after postoperative mediastinitis. J Thorac Cardiovasc Surg. 2006;132:537-43. (Pubitemid 44278895)
7. Baum SE, Dooley DP. Preventing methicillin-resistant Staphylococcus aureus infections in cardiovascular surgery patients: can we do any better? Clin Infect Dis. 2004;38:1561-3. (Pubitemid 38738551)
8. Bottio T, Rizzoli G, Vida V, Casarotto D, Gerosa G. Double crisscross sternal wiring and chest wound infections: a prospective randomized study. J Thorac Cardiovasc Surg. 2003;126:1352-6. (Pubitemid 37449161)
9. Schimmer C, Reents W, Berneder S, Eigel P, Sezer O, Scheld H, et al. Prevention of sternal dehiscence and infection in high-risk patients: a prospective randomized multicenter trial. Ann Thorac Surg. 2008;86:1897-904.
10. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical Practice Guidelines by the infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus Infections in Adults and Children. Clin Infect Dis. 2011;52:e18-55.
11. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66:82-98.
12. Vander Salm TJ. Reduction of sternal infection by application of topical vancomycin. J Throac Cardiovasc Surg. 1989;98:618-22. (Pubitemid 19248898)
13. Ozcan AV, Demir M, Onem G, Goksin I, Baltalarli A, Topkara VK, et al. Topical versus systemic vancomycin for deep sternal wound infection caused by methicillin-resistant Staphylococcus aureus in a rodent experimental model. Tex Heart Inst J. 2006;33:107-10. (Pubitemid 44299836)
14. Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM Jr, Grossniklaus HE, et al. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology. 2005;112:1151-8. (Pubitemid 40797475)
15. Fujimoto K, Yamamura K, Osada T, Hayashi T, Nabeshima T, Matsushita M, et al. Subcutaneous tissue distribution of vancomycin from a fibrin glue/Dacron graft carrier. J Biomed Mater Res. 1997;36:564-7. (Pubitemid 27388031)
16. Gårdlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery-microbiology and pathogenesis. Eur J Cardiothorac Surg. 2002;2:825-30. (Pubitemid 34308940)
17. Spicer PP, Mikos AG. Fibrin glue as a drug delivery system. J Control Release. 2010;148:49-55.
18. Patel S, Rodriguez-Merchan EC, Haddad FS. The use of fibrin glue in surgery of the knee. J Bone Joint Surg Br. 2010;92:1325-31.
19. Van Quill KR, Dioguardi PK, Tong CT. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology. 2005;112.
20. Lardinois D, Jung FJ, Opitz I, Rentsch K, Latkoczy C, Vuong V, et al. Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma. J Thorac Cardiovasc Surg. 2006;131:697-703.
21. Kuehn C, Graf K, Mashaqi B, Pichlmaier M, Heuer W, Hilfiker A, et al. Prevention of early vascular graft infection using regional antibiotic release. J Surg Res. 2010;164:e185-91.
22. Nishimoto K, Yamamura K, Fukase F, Kobayashi M, Nishikimi N, Komori K. Subcutaneous tissue release of amikacin from a fibrin glue/polyurethane graft. J Infect Chemother. 2004;10:101-4. (Pubitemid 38590733)
23. Woolverton CJ, Fulton JA, Salstrom SJ, Hayslip J, Haller NA, Wildroudt ML, et al. Tetracycline delivery from fibrin controls peritoneal infection without measurable systemic antibiotic. J Antimicrob Chemother. 2001;48:861-7. (Pubitemid 33735322)
24. Desmond J, Lovering A, Harle C, Djorevic T, Millner R. Topical vancomycin applied on closure of the sternotomy wound does not prevent high levels of systemic vancomycin. Eur J Cardiothorac Surg. 2003;23:765-70. (Pubitemid 36566571)
25. Tanemoto K. Experimental Study on Bacterial Colonization of Fibrin Glue and Its Prevention. Clin Ther 1994;16.
26. Morishima M, Marui A, Yanagi S, Nomura T, Nakajima N, Hyon SH, et al. Sustained release of vancomycin from a new biodegradable glue to prevent methicillin-resistant Staphylococcus aureus graft infection. Interact Cardiovasc Thorac Surg. 2010;1:52-5.
27. Drucker CR. Update on topical antibiotics in dermatology. Dermatol Ther. 2012;25:6-11.
28. Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas Keratitis. Ophthalmology. 1999;106:1319-23. (Pubitemid 30191478)
29. Alt V, Bitschnau A, Osterling J, Sewing A, Meyer C, Kraus R, et al. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials. 2006;27:4627-34. (Pubitemid 43783227)
30. Montali A. Antibacterial coating systems. Injury. 2006;37:81-6.